Literature DB >> 28652428

Grid-climbing Behaviour as a Pain Measure for Cancer-induced Bone Pain and Neuropathic Pain.

Sarah Falk1, Simone Gallego-Pedersen2, Nicolas C Petersen2.   

Abstract

Despite affecting millions of people, chronic pain is generally treated insufficiently. A major point of focus has been the lack of translation from preclinical data to clinical results, with the predictive value of chronic pain models being a major concern. In contrast to current focus on stimulus-based nociceptive responses in preclinical research, development of behavioural tests designed to quantify suspension of normal behaviour is likely a more equivalent readout for human pain-assessment tests. In this study, we quantified grid-climbing behaviour as a non-stimulus-evoked behavioural test for potential use as a measure of neuropathic and cancer-induced bone pain in mice. In both models, the grid-climbing test demonstrated pain-related sparing of the affected leg during climbing. In both models, the behaviour was reversed by administration of morphine, suggesting that the observed behaviour was pain-specific. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Pain behaviour; cancer-induced bone pain; chronic pain; grid climbing; neuropathic pain

Mesh:

Year:  2017        PMID: 28652428      PMCID: PMC5566911          DOI: 10.21873/invivo.11102

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  22 in total

1.  Efficient analysis of experimental observations.

Authors:  W J Dixon
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

Review 2.  Predictive validity of behavioural animal models for chronic pain.

Authors:  Odd-Geir Berge
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

3.  Bone cancer pain model in mice: evaluation of pain behavior, bone destruction and morphine sensitivity.

Authors:  Hilde Vermeirsch; Rony M Nuydens; Philip L Salmon; Theo F Meert
Journal:  Pharmacol Biochem Behav       Date:  2004-10       Impact factor: 3.533

Review 4.  Animal models of bone cancer pain: systematic review and meta-analyses.

Authors:  Gillian L Currie; Ada Delaney; Michael I Bennett; Anthony H Dickenson; Kieren J Egan; Hanna M Vesterinen; Emily S Sena; Malcolm R Macleod; Lesley A Colvin; Marie T Fallon
Journal:  Pain       Date:  2013-03-07       Impact factor: 6.961

Review 5.  Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans.

Authors:  G T Whiteside; A Adedoyin; L Leventhal
Journal:  Neuropharmacology       Date:  2008-01-12       Impact factor: 5.250

6.  Hypolocomotion, asymmetrically directed behaviors (licking, lifting, flinching, and shaking) and dynamic weight bearing (gait) changes are not measures of neuropathic pain in mice.

Authors:  Jeffrey S Mogil; Allyson C Graham; Jennifer Ritchie; Sara F Hughes; Jean-Sebastien Austin; Ara Schorscher-Petcu; Dale J Langford; Gary J Bennett
Journal:  Mol Pain       Date:  2010-06-08       Impact factor: 3.395

Review 7.  Translational pain research: achievements and challenges.

Authors:  Jianren Mao
Journal:  J Pain       Date:  2009-07-22       Impact factor: 5.820

8.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

9.  Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse.

Authors:  Anne-Frédérique Bourquin; Maria Süveges; Marie Pertin; Nicolas Gilliard; Sylvain Sardy; Anthony C Davison; Donat R Spahn; Isabelle Decosterd
Journal:  Pain       Date:  2006-03-20       Impact factor: 6.961

10.  Abnormal gait, due to inflammation but not nerve injury, reflects enhanced nociception in preclinical pain models.

Authors:  Michael J Piesla; Liza Leventhal; Brian W Strassle; James E Harrison; Terri A Cummons; Peimin Lu; Garth T Whiteside
Journal:  Brain Res       Date:  2009-08-03       Impact factor: 3.252

View more
  3 in total

1.  Identification of Altered Evoked and Non-Evoked Responses in a Heterologous Mouse Model of Endometriosis-Associated Pain.

Authors:  Miguel A Tejada; Ana I Santos-Llamas; Lesley Escriva; Juan J Tarin; Antonio Cano; Maria J Fernández-Ramírez; Paulina Nunez-Badinez; Bianca De Leo; Philippa T K Saunders; Victor Vidal; Florent Barthas; Katy Vincent; Patrick J Sweeney; Rowland R Sillito; James Douglas Armstrong; Jens Nagel; Raúl Gomez
Journal:  Biomedicines       Date:  2022-02-21

2.  Differential Pain-Related Behaviors and Bone Disease in Immunocompetent Mouse Models of Myeloma.

Authors:  Marta Diaz-delCastillo; Danna Kamstrup; Rikke Brix Olsen; Rie Bager Hansen; Thomas Pembridge; Brigita Simanskaite; Juan Miguel Jimenez-Andrade; Michelle A Lawson; Anne-Marie Heegaard
Journal:  JBMR Plus       Date:  2019-12-30

3.  Agmatine requires GluN2B-containing NMDA receptors to inhibit the development of neuropathic pain.

Authors:  Cristina D Peterson; Kelley F Kitto; Harsha Verma; Kelsey Pflepsen; Eric Delpire; George L Wilcox; Carolyn A Fairbanks
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.